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The rare case of the patient unwilling to disclose genetic data to his or her family
provides an opportunity to expand the atomistic conception of the autonomous
individual in medical decision-making. Medical practitioners naturally avoid violating
patient autonomy and privacy. However, unwilling disclosure can damage the health
of people other than the patient. In this situation, professionals must weigh the
principle of autonomy against the nature of relationships, duties, and confidentialities
between patient, professional, and family. The paradigm case studied is that of a patient
with a potentially dangerous heart condition, Long QT Syndrome 3. Patients with Long
QT 3 are at high risk for dying of ventricular tachycardia during rest, especially from
ages 40–60. Once familial genetic testing was completed, the proband's mother, who
was positive for the mutation, chose not to inform her estranged sister of the diagnosis.
This paper examines the ethical duties of the physician to inform a patient's extended
family of a serious genetic diagnosis, with a focus on the emotional and psychological
effects of genetic testing. The need to adapt the process of violating confidentiality
around considerations for the patient's emotional state and narrative will be addressed.
This approach considers the patient’s narrative, standpoint, and relationships as a way
to develop a support plan and will present a guideline for cases where the probability
of significant harm to others supersedes the patient’s preference of non-disclosure as
well as the physician’s respect of confidentiality. The paper seeks to expand the
conversation on genetic testing and autonomy beyond principles by considering all
parties involved and emphasizes the use of the varied resources available to medical
practitioners, especially to provide the best help possible without overburdening
physicians with duties.Case study
The proband, a 20-year-old male soccer player asymptomatic for cardiac illness, pre-
sents with an abnormal EKG at a routine physical. A second EKG confirms a pro-
longed QT interval, which is associated with an increased risk of sudden cardiac death.
However, given that the proband played soccer for many years with no symptoms, his
doctor reassures him that a positive diagnosis is unlikely. Genetic testing results in a
positive diagnosis of inherited long QT syndrome type III (LQT3). An electrical dis-
order of the heart caused by a mutation of cardiac ion channels, LQT3 can cause a
ventricular arrhythmia called torsades de pointes (TdP). TdP produces palpitations,
fainting, and can potentially cause sudden cardiac death due to ventricular fibrillation.2014 Gallagher; licensee Springer. This is an Open Access article distributed under the terms of the Creative Commons Attribution
icense (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium,
rovided the original work is properly cited.
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ample, patients with LQT3 are most at risk during sleep, especially between ages
40–60. LQT3 is among the most lethal forms of the disorder, but it is not particularly
common, striking around 10% of sufferers (NIH 2011). Other forms of LQTS can cause
arrhythmia during exercise or during high stress moments.
The proband’s family was referred for genetic counseling. Familial testing determined
that the proband’s mother was the carrier. The proband’s sister and father were nega-
tive for the mutation. The mother was then called in by her physician to determine
how to best inform family members. The mother told the physician that she had only a
sister with two children living in Florida. Both of the mother’s parents had passed away,
one due to stroke at age 64 and the other due to pneumonia at age 81.
When the doctor urged the mother to inform her sister, she replied, “Absolutely not.
I’m not calling her.” The physician offered a number of other modes of communication,
including mailing forms himself, but the mother stated that she did not want to open
any line of dialogue with the estranged sister. She said, “She would try to talk to me. I
don’t want to talk to her.” When the physician asked what might be causing these
negative feelings, the patient was unreceptive.
Given the risk of death for the estranged sister, the physician felt his hands were tied.
On one hand, the patient did not have a definitive, life-threatening illness. Rather, the
odds of dying from undiagnosed LQT3 are roughly 50% (NIH 2011). The physician did
not feel the duty to warn would apply from a legal or an ethical standpoint, but also felt
a strong desire to make sure this unknown woman knew the potential life changes ne-
cessary to make sure her risk of death was minimized. However, due to the legal con-
cerns surrounding the case, the physician erred on the side of safety and followed the
wishes of the proband’s mother. He turned to the American Medical Association
(AMA 2004) guidelines and found he had a minimal duty to inform the patient of her
risk. He left her with the advice, “You should inform your entire family.”Background
The risk for death for some undetected forms of LQTS can be serious. All forms of
LQTS have a death rate of approximately 9%, and LQT3 itself is the most lethal type of
the disease (NIH National Institutes of Health 2011). For LQT3, the largest risk factors
outside of general periods of rest are being an endurance athlete (resting heart rate
under 60 bpm) and taking drugs which induce QT prolongation (ibid). The list of QT-
prolonging drugs is vast, including most antihistamines and decongestants, diuretics,
statins, antidepressants, and many common antibiotics (NIH).
Generally, LQTS is treated through the use of beta blockers. However, where other forms
of LQTS worsen when the heart rate increases, LQT3 becomes worse when the heartbeat
slows. Therefore, LQT3 does not respond well to beta blockers. Patients with LQT3 can
regulate cardiac ion concentrations by supplementing their diet with sodium and potassium,
but the only medical intervention available is the use of an implantable cardiac defibrillator
(ICD) at the onset of symptoms.
Case law sets precedent to allow clinicians to warn parties outside the physician-patient
relationship if a patient intends harm to himself or others. The duty to warn was estab-
lished by the California Supreme Court's ruling in Tarasoff v. University of California. The
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stalked and murdered by a psychiatric patient at the University of California Berkeley,
Prosenjit Poddar. The court ruled that a clinician has a duty to not only her patients, but
society at large. If the patient intends to harm himself or others, confidentiality should be
breached in order to protect that patient and anyone she might harm (17 Cal. 3d 425).
That is, the harm incurred by breaching physician-patient confidentiality is less than the
harm potentially incurred by the patient to himself or to society.
Later case law is divided on other cases of duty to warn. Some states have statutes
that require a physician to warn her patients’ next of kin if the patient has HIV and in-
tends to engage in unprotected sex or share needles (Worth et al. 2008). In Pate v.
Threlkel, Heidi Pate sued her mother’s physician because he did not warn Ms. Pate of
her mother’s hereditary medullary thyroid cancer (MEN). Like LQTS, MEN is inherited
in an autosomal dominant pattern. Early diagnosis of MEN can allow for life-saving
intervention, but in Ms. Pate’s case, she was found to have advanced thyroid cancer
three years after her mother’s diagnosis. She filed suit, alleging that if the physician had
warned her of her mother’s genetic diagnosis early enough, Ms. Pate's disease progress
could have been halted (Offit et al. 2004). Essentially, the court decided that the stand-
ard of care sometimes is written to the benefit of third parties (662 Fla.). However, the
court also declared the duty of the physician fulfilled by warning the patient, not the
family. While the duty to warn extends to third parties, it is not required to inform
them. Two cases in New Jersey and New York, Safer v. Peck and Tenuto v. Lederle
Laboratories, extend the duty to warn immediate family members of risky hereditary
conditions and services like vaccinations which may incur harm to unimmunized family
members (90 NY2d 606).
The duty to rescue is a concept developed in tort law. Duty to rescue exists in two
situations: first, when one party creates a situation that is dangerous for another party;
second, when a party has a “special relationship” to another, such as a parent to a child
or spouses to each other (545 US 748). While case law does not extend the duty to res-
cue to siblings, it provides an interesting legal concept for the case. First, the mother
may have developed a situation that is dangerous for her sister – not informing the sis-
ter of a diagnosis that kills around one in ten of its sufferers. Second, her blood-
relatedness seems to imply a special relationship at least similar to that of the fiduciary
relationship owed by a physician to her patient. As a legal concept, duty to rescue has a
limited application – but when considered in the sense that one can owe a duty of res-
cue to a person of close blood-relatedness, may have value in an ethical analysis.
While some state courts extend a vague duty to warn immediate family members
with potential risk, physicians and professional societies remain more cautious. The
AMA (2007), American Society of Human Genetics, and American Society of Clinical
Oncology agree on some variation of the AMA policy: physicians should inform pa-
tients of circumstances under which confidentiality would be breached and to “make
themselves available to assist patients in communicating with relatives to discuss op-
portunities for counseling and testing, as appropriate,” but that duties are fulfilled by
disclosing genetic results to the patient alone. Physicians tend to follow this rule - a
survey of 800 practicing or formerly practicing geneticists showed that only 23% of the
sample would be willing to disclose information to a patient’s family even if the risk to
the family member was high (Falk et al. 2003).
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chiatric patients, terminal genetic conditions like Tay-Sachs or Huntington’s, or even
some HIV disclosure cases, doctors are often more aware of impending and largely def-
inite harm than in genetic predispositions like LQTS. In a purely practical sense, a
physician would need to parse out a number of different rules in order to determine
whether a disclosure is necessary. The duty of care in this case would depend on esti-
mated risk to a given family member. Physicians naturally exercise caution when the
patient is unwilling to disclose to at-risk relatives. The dichotomy between the law and
actual practice indicates the difficulties inherent to decision-making about the disclos-
ure of genetic dispositions. While physicians may not be required to actively lie or
withhold information, as might be the case with exercising therapeutic privilege for a
cancer diagnosis to a very optimistic but fragile patient, they can be inclined by the
standard of care not to inform at-risk people. The physician can violate the basic re-
spect for the autonomy of his patient to potentially save another life, or fulfill the min-
imal responsibility to his patient but allow the other life to hang in the balance.
While the traditional normative ethical theories, such as principlism or utilitarianism,
might be useful in less complex situations, there are clearly multiple conflicts of basic
principles and parties here. Beauchamp and Childress (2001) write that autonomy
serves as a "right, not a duty of patients.” That is, the patient's right to make decisions
for a treatment course must be protected by all parties but that autonomous decision-
making is not demanded in all cases. Moreover, the two authors argue the professional’s
obligation to the patient is "respectful treatment in disclosing information and fostering
autonomous decision-making" (ibid). This conception of autonomous action empowers
the individual to make decisions and avoids medical parentalism. Balancing principles
can be difficult without a view into the reasoning of both parties in a conflict. The
mother's autonomy and trust in the physician-patient relationship is significantly di-
minished by disclosure, but a life is potentially saved. Physicians also possess a duty to
warn in order to avoid deliberately allowing a harm otherwise preventable with genetic
testing information. Yet probability remains a factor that renders principles difficult to
use - the sister not have the disease, may never present symptoms, or may die.
Feminist and narrative methods remind the ethicist to find a degree of understanding
with the perspective of the patient. Both theories tend to focus on humanizing the parties
involved in ethical dilemmas, rather than applying rigid rules or principles to a situation.
On the other hand, narrative and feminist ethics tend to provide very vague or even no
solutions to ethical dilemmas. Questions of a person's life story, standpoint, or autonomy
in relation to others are still arguably best served by these methods. By obtaining a picture
of the whole person, narrative ethics can shift the focus of disclosure dilemmas from vio-
lating rules or duties to changing perceptions. Alternative methods to traditional norma-
tive means supplement the principlist conception of autonomy with relational aspects,
balancing interconnectedness rather than simple individual action.Emotional and relational issues
The nature of the patient's emotions and relationships can determine the extent to
which the patient is willing to disclose. At the outset of a genetic diagnosis, emotions
tend to run high but wane with time. Aatre and Day (2011) document a number of
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ance to outright fear. Interview studies have shown that genetic testing can leave a pa-
tient feeling devastated. One patient said, “I was thinking, what other genes are also
defective? [. . .] I also wanted to take on a new identity” (Porz 2009). Genetic testing re-
sults produce issues of identity crises because they make people feel as if they are no lon-
ger self-governing. Patients report feeling “powerless, disoriented, confused” (Porz 2009).
The body can now be seen to harbor dangerous genetic flaws or defects and the patient is
reminded strongly of their own mortality. The mother in the case study may have felt
similarly adrift, and also may have dealt with guilt over passing the disease on to her son.
Quality of life may be adversely affected, further adding to questions of her future.
Looking at the standpoint of the mother in the case study, she likely feels some degree of
guilt over passing this disease on to her child. As a 20-year-old soccer player, her son might
be denied the chance to continue playing his sport, or any contraindicated competitive sport,
should he inform anyone of his diagnosis. Even without symptoms, a positive LQTS diagno-
sis is typically enough for a physician to recommend against competitive sports Pelliccia et al.
(2005). The mother may be transferring the role of the denier to herself, allowing herself to
feel as if "her" disease has guaranteed the son's loss of autonomy. Since the proband was
asymptomatic, the mother might feel as if there is no risk to her sister, that nothing truly
wrong with her son, and may even mistrust the diagnosis. She could therefore justify nondis-
closure by the increasingly present reality of probabilities in her life, thinking, "My son had
only a 50% chance of getting this from me, my daughter did not get it, and I only had a 50%
chance of getting it from my mother." Taken together, the mother may feel that disclosure is
unnecessary because her sister simply does not seem to be under any realistic risk.
Another valuable consideration in the case of such significantly diminished autonomy
is the idea of control (Aatre and Day 2011). Inherited diseases wrest the power over
one's body from the individual and place it in the hands of chance. The establishment
of control could be expressed through a number of outlets, including "self-education,
maintaining privacy, and active participation in treatment decisions" (ibid). Mainten-
ance of privacy speaks to the case study, where the mother may be seeking to keep se-
crecy surrounding her condition. Secrecy can be a method of control, as it allows the
patient to determine with whom she discusses the diagnosis. The emotional nature of
disease can be a difficult subject to broach for people with whom one is uncomfortable,
especially when the diagnosis is potentially life-threatening. While legal precedent ar-
gues for a duty to warn and the right-to-know, patients have their own perceptions of
that right to know. A patient may feel that a genetic diagnosis is his or hers alone, not
focusing on the importance of extending that diagnosis to his immediate family.
The desire to obtain control in a situation of diminished autonomy can also be tied to the
establishment of relational dynamics. Feminist ethics can be useful in examining how rela-
tional dynamics affect the situation. Nodding's care ethics provides a relatively simple defin-
ition of what variations on relationships exist in the case. For example, the physician-patient
relationship would be described as a "caring-for" relationship where the face-to-face encoun-
ters between the one-caring (physician) and cared-for (patient) create a direct relationship
(2001). The indirect relationship between the physician and the patient's sister seems closer
to "caring-about," which Noddings identifies as having a "benign neglect" (2002). However,
caring-about is somewhat foundational, establishing the basics for caring-for and a general
sense of social justice.
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conflicted over the disclosure case. His sense of justice tells him it is fair for the sister to
know information that can affect her future, but directly violating the patient's autonomy
seems a greater offense than indirectly and only potentially harming an unfamiliar outsider.
With the knowledge granted by the mother's genetic test, the physician can prevent a po-
tential harm. It is this sort of more egalitarian sense of weighed duties that causes problems
for a physician. Either perspective, respect for the mother’s autonomy or nonmaleficence to-
wards her sister, places the burden on deciding in favor of a single party. The desire to cre-
ate a fair, just reality for both people establishes the conflict and is arguably impossible to
satisfy with an ethic that focuses purely on individuals and not on relational communities.
Arguably, the mother is marginalizing her sister by denying her sister access to the
reality of her genetic illness. This ties into the concept of causal relational autonomy,
where an outside factor (the mother) reduces the autonomy of a moral agent (the sis-
ter). One formulation of this version of autonomy involves a theory of "significant op-
tions" available to an autonomous agent at the time of a decision (Brison 2000). That
is, an agent must have the proper grasp of all external factors in order to have the op-
tions necessary for a decision. The sister may be acting in an entirely autonomous man-
ner, but her decisions could be altered by the knowledge that she has a genetic illness.
On one hand, an LQTS diagnosis might constrain her actions in a more significant way
than not having a diagnosis would. However, the proband's mother has knowledge that
prevents her sister from making a fully informed decision. The sister lacks all available
options - for example, she could choose not to run a marathon because doing so might
put her at risk of arrhythmia. By knowingly withholding key information, the mother
reduces her sister's ability to make choices about her lifestyle and the lifestyles of her
children. Feminist theorist Annette Baier argues, "persons are essentially successors,
heirs to other persons who formed and cared for them" (Baier 1985). That is, the
patient's caring-for her sister influences how her sister can exercise autonomy. The sis-
ter may be an autonomous agent without knowledge of her genetic illness, but the
mother has tools to allow her sister a deeper knowledge of the risks involved in her
day-to-day activities. In essence, the broken social relationship between the proband's
mother and her sister has reduced the sister's ability to make informed choices.
Obviously, these considerations place strain on the principle of individual autonomy.
However, it is arguably the focus on autonomy in modern medical ethics which creates
the conflict in this case. Feminist theorists recognize that autonomy develops from a
conflation of external influences - from personal relationships to the social framework
a person inhabits. This context for autonomy reminds the ethicist that free decisions
come from a personal narrative, influenced by the encounters and experiences of life.
In essence, the autonomous individual cannot separate himself from the outside com-
munity in any way. While the case study may not merit a violation of autonomy
through disclosure, it does remind the ethicist that medicine cannot always concern it-
self solely with the individual patient and professional. Other parties are almost invari-
ably involved, be it the impoverished person who might be harmed by improper
resource allocation or the sibling whose well-being is threatened by a nondisclosure.
Moreover, human reason can be fallible, especially with regard to the future (Levy,
2011). Perhaps a trajectory towards a more communitarian ethic, based in the related-
ness of people through their interactions and social development, is needed.
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professionals who held complete power. In doing so, however, medicine tipped the bal-
ance too far by ignoring the possibility of constraining patient autonomy. The dynamic
fostered by a communitarian ethic would ideally be one of support and understanding,
where the medical team is responsible for providing care to a patient in interaction
with that team. The current dynamic fosters much advice-giving on the part of the
medical team and much decision-making for the patient, but rarely do the two meet as
equals. Suggestions for care could be made by both parties and considered with medical
expertise and patient values in mind, but a balance could be struck between the patient
and physician’s empowerment.
Rouven Porz attempts to adapt Monica Konrad’s “kinship ethics” to situations similar to
this one, arguing that the principles valued by medical ethics are insufficient for family
members struggling with genetic data. One important principle Porz emphasizes is the
idea of loyalty to family members and the relatedness of the human species. Genetic test-
ing unites a person with a larger web of the “new genetic family,” the sort of extended
family network developed through awareness of a genetic disease (Porz 2009). “Genetic
constitution,” not blood relatedness, determines the interrelatedness of the genetic family
(ibid). Therefore, genetic disclosures can become an issue of loyalty between members of
a community composed of more than private individuals or separate unit of blood rela-
tives. Altruism can be one way a family member fulfills this loyalty - the outright giving-
away of genetic information. However, for more distant genetic relatives, that sense of al-
truism may not be present. Kinship offers a second alternative: reciprocity. The reciprocal
sharing relationship between two people provides a secondary outlet for genetic informa-
tion. The narrative of genetic interconnection expands responsibilities of sharing to a lar-
ger community through a transformation of the personal narrative.
Kinship theory removes the feeling of a patient’s ownership of their genetic information
by establishing the idea that a given mutation is not unique. Rather, the patient is part of a
continuing family narrative, reaching into the past and potentially extending into the fu-
ture. The owed debt to this family means that while the mother in the case study can
withhold information about her treatment for Long QT, she cannot withhold information
about the family having a genetic history which predisposes its members to LQTS. This
conception of the narrative can provide the physician with a way to frame the situation
for the mother. Consider, for example, the idea of duty to rescue for someone with an un-
derstanding of kinship ethics. As one’s genetic network expands, the duty to rescue can be
owed to a number of genetic relations – family members at risk for inheriting a disease.
Combined with the obligation of rescue or the strength of altruistic intentions, kinship
ethics can become a valuable determining factor for disclosure practices.Suggestions for practice
Knowledge of the different ways in which one's life story can be interpreted is useless
without a way to inform the patient of these new concepts. Patient education is one of
the most commonly used parts of dealing with difficult issues in the doctor's office. Yet
a study of patients with hereditary colorectal cancer, who used educational materials
like letters and booklets to understand their disease, did not show significant differ-
ences in knowledge compared to control group without the additional material
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dent and professional attitudes conflict. The principle of doctor-patient confidentiality
presents an ethical reason not to disclose, and geneticists often feel bound by the lim-
ited code of the American Society of Human Genetics, but many are unaware of the
professional code (Falk et al. 2003). Even those physicians with knowledge of profes-
sional codes report their duty is typically to inform the patient, and no other duty is
required to next-of-kin (ibid).
The general tendency to avoid disclosure points to a significant valuation of privacy
and consent. Therefore, a novel approach for reopening communication might be the
establishment of an alternative narrative. The concept of the kinship narrative has
already shown such an alternative conception is possible. However, the new narrative is
only valuable if it can be used to facilitate communication between at-risk relatives. If
providing educational material fails the patient, then perhaps perceptual or behavioral
changes succeed.
Providing this sort of perceptual change can seem difficult for one physician to ac-
complish. The increasing awareness of fragmented care in the medical field has led to
much pressure on the physician to improve her practice by becoming a sort of scion of
morality, competence, and altruism, a Renaissance man operating with ever-limited
time for each patient. The duty to contact and warn an estranged relative, as in the case
study, might be seen as an example of this. Steel (2009) presents a similar example -
the patient does not want to disclose a life-threatening diagnosis to his estranged
cousin in Australia. The physician obviously cannot spend the time finding contact in-
formation for this remote cousin without cooperation from the patient. Even in less
drastic situations, the physician needs another party to carry some of the burden.
A practical suggestion would be to place responsibility in the hands of other health
care services. A patient struggling with the emotions of a genetic diagnosis or disclos-
ure can be referred to therapeutic counseling. There, a professional can provide the ne-
cessary tools to explore the issues the patient may have with both the disease and the
relationship with her sister. Obviously, therapy sessions require that a patient accept
the idea of going to therapy as a net good. However, counseling has been offered for an
increasing number of conditions which might require significant lifestyle adaptation for
a patient. There is no reason to avoid working through the emotions of someone with
a difficult diagnosis, no matter what form that diagnosis takes. If counseling should
succeed in making the patient more comfortable with disclosure, then the geneticist
can go forward with referring at-risk family members.
A second route for a physician might be an outright breach of confidentiality. Con-
cerns for autonomy and the physician-patient relationship mean this should be a last
resort reserved for extreme situations, but a threshold of likelihoods across which dis-
closure would be permissible can be useful. In any case, respect for autonomy means
that a significant burden of proof is placed upon a geneticist breaching confidentiality
and that the patient must be informed of a last-resort policy before any testing occurs,
in accordance with the AMA’s policy recommendations.
This decision-making process does not come without its risks. Since genes only con-
vey probabilities in many situations, decision-making cannot be reduced to seeing if a
gene is present or not. For LQT3 patients, the presence of the gene only conveys a
probability of passing it along to descendants and an additional probability of cardiac
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from reductionism by emphasizing the effects of the environment and other non-gene
directors of genetic expression. However, in making decisions to weigh potential inher-
itance and potential harm, physicians need to be careful that they rely on realistic risk
and not simply knowledge that the gene is present in a patient. Not all genes in a given
patient will penetrate to all family members, and even penetrant genes may not be
expressed or produce symptoms. To force the mother to disclose simply because the
LQT3 gene was present in her body would border on discrimination. Adequate weigh-
ing of risk and benefit must come before a disclosure decision.
Disclosures might be best when the following criteria are met:
(1)the at-risk family member can be contacted,
(2)the illness has a high chance of inheritance (greater or equal to 50%),
(3)the illness will eventually be serious and life-threatening,
(4)interventions (treatment or lifestyle changes) can cure or significantly reduce the
effects of the disease,
(5)the patient is adamant with regard to non-disclosure
These considerations outweigh the potential harm to the proband's autonomy be-
cause a significant preventable harm can be overcome by the violation of confidential-
ity, similar to the legal right to the duty to warn enshrined after Tarasoff. On one hand,
the proband might be denied the sense of control he desires. However, the uninformed
at-risk party would be denied knowledge which could prevent greater losses, such as
preventable debilitation or death.
If applied to the case under analysis, such criteria would likely not be enough to jus-
tify a disclosure because the likelihood of death is relatively low. Moreover, no interven-
tion short of an ICD could affect the disease course. Given that ICDs are generally only
implanted at the onset of symptoms, the most that could be done for the sister would
be reducing participation in strenuous competitive sports and perhaps changing the
diet. There exists little reason to breach confidentiality here, but other cases would cer-
tainly merit this saving grace. What, then, can be done for the mother? Certainly coun-
seling sessions can be offered, as her life has changed drastically and she seems to be
struggling with family connectedness. Time may be the only way to reach a reasonable
disclosure – however, unilateral decision-making on the part of the physician would
represent both a gross violation of patient rights and a discriminatory act.
The sister in the case might act differently if she knows she suffers from LQTS, and
the focus on autonomy in medical practice neglects that potentiality by valuing only
the decision-making of the person in front of the doctor. Yet narrative and relational
methods rely on just these sort of connections by recognizing the value of interpersonal
effects on decision-making. While a libertarian ethic of medicine protects the individual
patient from the individual practitioner, it fails to reflect on the full scope of decisions
and harms caused to outside parties by overvaluing singular moral agents.
Principlism has succeeded in providing medical ethics with a basis around which to
develop patient rights but has arguably failed in adequately ensuring a humanistic dia-
logue between physician and patient by overemphasizing autonomy. However, princip-
lism need not be discarded, as it offers helpful points on which case decisions can be
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the life narrative of the patient and physician, reminding both of their indebtedness to
society and those who helped them weave those narratives. Autonomy should not be
considered "first" among equals, but rather one of many goals towards which good
medical practice strives. People are not merely gaseous molecules, sometimes brushing
past each other but otherwise on their own. Every person interacts frequently with the
outside world, and the decisions made by a given person can have implications for
many others. This kinship indicates while autonomy might be a valuable political con-
cept, it is neither a psychological nor social one. People, whether they are professionals
or patients, form a network of supports and constraints. Decisions made "autono-
mously" often echo through this network, changing the circumstances for other people.
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